The United Kingdom is experiencing a growing interest in mind-altering compounds , particularly N,N-Dimethyltryptamine and Cannabigerol . Scientists are progressively exploring the possibilities of these chemicals for medical purposes, prompting a evolving discussion around their regulatory position and mindful integration. While prohibitions remai